Association between dietary fatty acids and all‐cause mortality in patients with cirrhosis: A cohort study

Abstract Liver cirrhosis imposes a substantial global burden, with complications driving high mortality. Diet is pivotal in managing liver disease progression and cirrhosis‐related death. This study investigated associations between total fat intake, specific dietary fatty acid subclasses and all‐cause mortality in cirrhotic patients. In this prospective cohort study, 121 ambulatory patients with recently diagnosed cirrhosis (≤6 months) were enrolled. Baseline dietary intake was evaluated via a validated 168‐item semi‐quantitative food frequency questionnaire. Participants were categorized into tertiles by total fat and fatty acid subclasses: saturated (SFA), monounsaturated (MUFA), polyunsaturated (PUFA), omega‐3 and omega‐6 fatty acids. Cox proportional hazards models computed hazard ratios (HRs) and 95% confidence intervals (CIs), adjusted sequentially for age, sex, energy intake, BMI, smoking, alcohol use, cirrhosis aetiology, MELD score and Child–Pugh class. During the 60‐month follow‐up, 50 deaths (41.3%) occurred. In fully adjusted models, highest versus lowest tertiles of total fat intake (HR = 6.69; 95% CI: 1.37–13.34; P ‐trend = 0.017), SFA intake (HR = 8.2; 95% CI: 1.33–20.53; P ‐trend = 0.014) and PUFA‐6 intake (HR = 5.24; 95% CI: 1.1–26.44; P ‐trend = 0.014) were independently associated with significantly elevated mortality risk. No significant associations were observed for MUFA, total PUFA or PUFA‐3 intake. Kaplan–Meier analyses confirmed significantly reduced 5‐year survival with higher total fat (log‐rank P = 0.003) and SFA intake (log‐rank P < 0.001). In this exploratory prospective cohort study, higher intakes of total fat, saturated fatty acids and omega‐6 polyunsaturated fatty acids were associated with increased all‐cause mortality among patients with cirrhosis. These preliminary findings are hypothesis‐generating and require confirmation in larger, adequately powered prospective studies.

Authors

Institutions

Publication Details

Journal
Experimental Physiology
Published
2026-09-28
DOI
https://doi.org/10.1113/ep093526
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Association between dietary fatty acids and all‐cause mortality in patients with cirrhosis: A cohort study

Behzad Hatami, Fereshteh Pashayee-Khamene, Ali Jafari, Behnaz Narimani et al.
Experimental Physiology
Liver Disease and Transplantation
article

Association between dietary fatty acids and all‐cause mortality in patients with cirrhosis: A cohort study

Behzad Hatami, Fereshteh Pashayee-Khamene, Ali Jafari, Behnaz Narimani, Saleheh Ahmadzadeh, Mehdi Saberifiroozi, Zahra Yari, Helia Mardani, Ghazaleh Mahdavi-Mazdeh, Sara Karimi, Azita Hekmatdoost
article en

Abstract

Abstract Liver cirrhosis imposes a substantial global burden, with complications driving high mortality. Diet is pivotal in managing liver disease progression and cirrhosis‐related death. This study investigated associations between total fat intake, specific dietary fatty acid subclasses and all‐cause mortality in cirrhotic patients. In this prospective cohort study, 121 ambulatory patients with recently diagnosed cirrhosis (≤6 months) were enrolled. Baseline dietary intake was evaluated via a validated 168‐item semi‐quantitative food frequency questionnaire. Participants were categorized into tertiles by total fat and fatty acid subclasses: saturated (SFA), monounsaturated (MUFA), polyunsaturated (PUFA), omega‐3 and omega‐6 fatty acids. Cox proportional hazards models computed hazard ratios (HRs) and 95% confidence intervals (CIs), adjusted sequentially for age, sex, energy intake, BMI, smoking, alcohol use, cirrhosis aetiology, MELD score and Child–Pugh class. During the 60‐month follow‐up, 50 deaths (41.3%) occurred. In fully adjusted models, highest versus lowest tertiles of total fat intake (HR = 6.69; 95% CI: 1.37–13.34; P ‐trend = 0.017), SFA intake (HR = 8.2; 95% CI: 1.33–20.53; P ‐trend = 0.014) and PUFA‐6 intake (HR = 5.24; 95% CI: 1.1–26.44; P ‐trend = 0.014) were independently associated with significantly elevated mortality risk. No significant associations were observed for MUFA, total PUFA or PUFA‐3 intake. Kaplan–Meier analyses confirmed significantly reduced 5‐year survival with higher total fat (log‐rank P = 0.003) and SFA intake (log‐rank P < 0.001). In this exploratory prospective cohort study, higher intakes of total fat, saturated fatty acids and omega‐6 polyunsaturated fatty acids were associated with increased all‐cause mortality among patients with cirrhosis. These preliminary findings are hypothesis‐generating and require confirmation in larger, adequately powered prospective studies.

Experimental Physiology
Ahvaz Jundishapur University of Medical Sciences (IR), National Nutrition and Food Technology Research Institute (IR), Shariati Hospital (IR), Digestive Disease Research Institute, Research Institute for Gastroenterology and Liver Diseases (IR), Shahid Beheshti University of Medical Sciences (IR), Tehran University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 14%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.